Table of Contents
Research & Development
| Regeneron and Telix Pharmaceuticals Sign US$4.3 B Radiopharmaceutical Oncology Deal | Abstract pdf html |
| Hitesh Udar |
Mergers & Acquisitions
| Gilead to Acquire ADC Specialist Tubulis for US$5 B | Abstract pdf html |
| Lucy Haggerty |
| UCB Strengthens Epilepsy Portfolio with US$1.15 B Acquisition of Neurona Therapeutics | Abstract pdf html |
| Naini Anand |
| Neurocrine Biosciences Expands Rare Disease Portfolio with US$2.9 B Acquisition of Soleno Therapeutics | Abstract pdf html |
| Nikita Negi |
This work is licensed under a Creative Commons Attribution 3.0 License.